No abstract available
Keywords:
arthritis; autoimmune diseases; biological therapy; rheumatoid.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / therapeutic use
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / drug therapy
-
Autoimmune Diseases / complications
-
Autoimmune Diseases / drug therapy*
-
Azithromycin / therapeutic use
-
Biological Products / therapeutic use
-
COVID-19 / complications
-
COVID-19 / mortality
-
COVID-19 / therapy*
-
COVID-19 Drug Treatment
-
Enzyme Inhibitors / therapeutic use
-
Female
-
Glucocorticoids / therapeutic use
-
Hospitalization
-
Humans
-
Hydroxychloroquine / therapeutic use
-
Immunomodulation
-
Immunosuppressive Agents / therapeutic use*
-
Inflammatory Bowel Diseases / complications
-
Inflammatory Bowel Diseases / drug therapy
-
Intensive Care Units
-
Janus Kinase Inhibitors / therapeutic use
-
Male
-
Middle Aged
-
Respiration, Artificial
-
SARS-CoV-2
-
Sarcoidosis / complications
-
Sarcoidosis / drug therapy
-
Surveys and Questionnaires
-
Tumor Necrosis Factor Inhibitors / therapeutic use
-
Young Adult
Substances
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Biological Products
-
Enzyme Inhibitors
-
Glucocorticoids
-
Immunosuppressive Agents
-
Janus Kinase Inhibitors
-
Tumor Necrosis Factor Inhibitors
-
Hydroxychloroquine
-
Azithromycin
-
tocilizumab